National Bank of Canada
BMRN icon

National Bank of Canada’s BioMarin Pharmaceuticals BMRN Stock Holding History

National Bank of Canada’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,600
Closed -$1.64M – 2981
2025
Q4 		$1.64M Buy
27,600
+26,311
+2,041% +$1.43M ﹤0.01% 1107
2025
Q3 		$69.8K Sell
1,289
-44
-3% -$2.52K ﹤0.01% 1851
2025
Q2 		$73.3K Buy
1,333
+365
+38% +$21.5K ﹤0.01% 1870
2025
Q1 		$68.4K Sell
968
-10
-1% -$673 ﹤0.01% 1791
2024
Q4 		$64.3K Buy
978
+59
+6% +$3.95K ﹤0.01% 1870
2024
Q3 		$64.6K Sell
919
-13,464
-94% -$1.13M ﹤0.01% 1639
2024
Q2 		$1.18M Sell
14,383
-209,522
-94% -$17.4M ﹤0.01% 1030
2024
Q1 		$18.1M Sell
223,905
-44,702
-17% -$4M 0.03% 444
2023
Q4 		$26.3M Sell
268,607
-342,304
-56% -$30.3M 0.04% 345
2023
Q3 		$53.2M Buy
610,911
+592,585
+3,234% +$52.7M 0.08% 219
2023
Q2 		$1.57M Buy
18,326
+10,385
+131% +$977K ﹤0.01% 1043
2023
Q1 		$768K Sell
7,941
-721
-8% -$74.7K ﹤0.01% 1134
2022
Q4 		$896K Sell
8,662
-1,805
-17% -$169K ﹤0.01% 1112
2022
Q3 		$907K Sell
10,467
-2,712
-21% -$241K ﹤0.01% 1014
2022
Q2 		$1.12M Sell
13,179
-16,014
-55% -$1.28M 0.01% 984
2022
Q1 		$2.29M Buy
29,193
+17,352
+147% +$1.45M 0.01% 831
2021
Q4 		$1.03M Buy
+11,841
New +$977K ﹤0.01% 1045

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada's BMRN Position: Q1 2026 in Review

National Bank of Canada sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 27,600 shares — an estimated $1.64M sold.

National Bank of Canada first reported a position in BMRN in Q4 2021 and held it in 17 quarters. The position peaked at $53.2M in Q3 2023. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • National Bank of Canada reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 27,600 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $1.64M.
  • National Bank of Canada first reported a position in BioMarin Pharmaceuticals in Q4 2021 and held it in 17 quarters.
  • National Bank of Canada's BioMarin Pharmaceuticals position peaked at $53.2M in Q3 2023.
  • 555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.